BridgeMD
New treatment option for Donor Site Complication
Official title Blue Light for Donor Site Healing in Burn Patients
ClinicalTrials.gov ID: NCT07453927
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn whether blue light (BL) photobiomodulation can improve the healing of donor site (DS) wounds in patients with burn injuries who are treated surgically. This study will investigate whether adding BL therapy to the usual treatment can improve healing and patient outcomes in adult patients with intermediate and deep burns.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients with intermediate-deep burns with Total Body Surface Area (TBSA) \> 10% requiring surgical treatment with escharectomy, presenting at least...
- Patients over 18 years of age;
- Patients who have signed the informed Consent Form (ICF) and understood the purpose of the study, or, if unable to give consent personally due to...
You likely can't join if
- Intermediate-deep burns TBSA \< 10% or superficial burns;
- Patients under the age of 18;
- Patients who are participating in other clinical trials with drugs or medical devices;
- Patients with neoplasms or other conditions requiring the use of cytostatic or immunosuppressive drugs;
- Patients with conditions that induce skin photosensitivity;
- Pregnant or breastfeeding women;
See the full eligibility criteria
- Patients with intermediate-deep burns with Total Body Surface Area (TBSA) \> 10% requiring surgical treatment with escharectomy, presenting at least two Donor Site.
- Patients over 18 years of age;
- Patients who have signed the informed Consent Form (ICF) and understood the purpose of the study, or, if unable to give consent personally due to their condition, their legal guardian.
- Intermediate-deep burns TBSA \< 10% or superficial burns;
- Patients under the age of 18;
- Patients who are participating in other clinical trials with drugs or medical devices;
- Patients with neoplasms or other conditions requiring the use of cytostatic or immunosuppressive drugs;
- Patients with conditions that induce skin photosensitivity;
- Pregnant or breastfeeding women;
- Patients or relatives who are unable to understand the purposes of the trial;
The study team makes the final eligibility decision.
Where it's taking place
- Cesena, Forlì-Cesena, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cesena, Forlì-Cesena, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.